Selling into China without an Entity and Where That Stops
Cross-border selling without a China entity works via DDP or agents but stops when local fapiao, restricted licences, or onshore service teams create tax PE.
National Medical Products Administration
Meaning
This executive department under the State Administration for Market Regulation is the primary authority for the oversight of drugs and medical devices and cosmetics. The national medical products administration is responsible for the registration and the licensing and the safety monitoring of these products within the jurisdiction. It establishes the standards for manufacturing and clinical trials and distribution to ensure the quality and the efficacy of medical supplies.
For a foreign company, this agency is the gatekeeper that determines whether a product can be sold in the market. The administration oversees the entire life cycle of a product from initial research to post market surveillance. Its authority stops at the boundary of non medical health products or general consumer goods that do not make medical claims.
This department is essential for protecting the public health and for regulating the growth of the healthcare industry. It manages the approval of both imported and domestically produced medical items.
Product Approval
The process of getting a new drug or medical device to market involves a rigorous review of the technical data and the clinical trial results. Manufacturers must submit a detailed application to the national medical products administration that includes information on the composition and the manufacturing process and the intended use. The agency evaluates the safety and the effectiveness of the product through a series of technical reviews and expert panels.
For certain high risk devices or innovative drugs, a local clinical trial may be required to demonstrate the performance in the local population. This requirement can add significant time and cost to the market entry process for foreign firms. Once the administration is satisfied with the evidence, it issues a registration certificate that allows the product to be sold for a specific period.
This certificate must be renewed and the holder must report any changes in the product or its manufacturing. The approval process is designed to ensure that only products that meet the highest standards are available to patients.
Clinical Standard
The agency sets the rules for how clinical trials must be conducted to ensure the protection of the participants and the reliability of the data. All trials must be registered with the national medical products administration and must follow the principles of good clinical practice. The administration has the power to inspect the trial sites and the data records to verify the integrity of the results.
This oversight extends to the ethical review process and the informed consent of the patients. For foreign companies, the challenge is to align their global trial protocols with the specific requirements of the local regulator. The agency may also recognize data from international trials under certain conditions, which can speed up the approval process.
However, the final decision always rests on whether the data meets the national standards for safety and efficacy. This focus on clinical excellence is a pillar of the regulatory framework and ensures that new treatments are thoroughly vetted. The administration also monitors the manufacturing sites through good manufacturing practice audits to ensure consistent quality.
Safety Oversight
Once a product is on the market, the administration continues to monitor its performance through a system of adverse event reporting and periodic inspections. Manufacturers and healthcare providers are required to report any serious side effects or malfunctions to the agency. The national medical products administration can issue safety alerts or order a product recall if it detects a risk to the public.
It also conducts random sampling and testing of products from the market to verify their quality. This post market surveillance is essential for identifying long term safety issues that may not have been apparent during the initial trials. The agency also regulates the advertising and the promotion of medical products to prevent the making of false or misleading claims.
If a company is found to be in violation of these rules, it faces fines and the revocation of its licenses. This continuous oversight ensures that the safety of the patients remains the top priority throughout the life of the product. The role of the administration is a fundamental part of the healthcare system and the protection of the public.